Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) is a clinical research site located in San Antonio, Texas, United States 78229.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) has participated in 2 clinical trials.
Therapeutic areas: Relapsed or Refractory Multiple Myeloma, Breast Cancer, Hematologic Neoplasms.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) has 2 clinical trials on record. Their work covers Relapsed or Refractory Multiple Myeloma, Breast Cancer, Hematologic Neoplasms.
Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.